1Sonnenberg GE, et al. The Annals of Phamacotherapy 1997; 31(6):671-6.
2Rosskamp R, et al. 15th International Diabetes Federation Congress(1995).Abstract 10AS PP1050.
3Simonson DC, Kourides IA, Ffeinglos M, et al. Efficacy, safety, and dose- reponsecharacteristics of glypizide gastrointestinal therapeutic system on glycemiccontrol and insulin secretion in NIDDM. Diabetes Care 1997;20:597-606.
4Cefalu WT, Bell - Farrow AD, Wang ZQ, et al. Insulin sensitive in vivo is improvedafter glipizide GITS treatment. Diabetes 1995 ; 44 (Suppl) : 107A.
5Riddle MC, McDaniel PA, Tive LA. Glipizide GITS does not increase thehypoglycemic effect of mild exercise during fasting in NID- DM. Diabetes Care 1997 ; 20 : 992 - 994.
